Advertisement

Topics

Triphase Accelerator Corporation Company Profile

13:40 EST 21st January 2019 | BioPortfolio

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to advancing novel compounds through Phase 2 proof-of-concept clinical studies using a unique, science-based, high-quality model that is faster and more cost-effective than traditional pharmaceutical and biotech industry drug development approaches. Triphase Accelerator was spun out of the Ontario Institute for Cancer Research (OICR), with support from the Fight Against Cancer Innovation Trust (FACIT), MaRS Innovation and MaRS. It has a strategic relationship with Celgene for oncology-focused drug development opportunities. For more information, visit www.triphaseco.com or Linkedin.


News Articles [248 Associated News Articles listed on BioPortfolio]

Triphase Accelerator Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 13082018] Prices from USD $250

SummaryTriphase Accelerator Corp Triphase Accelerator is a biotechnology development company that acquires and develops novel therapeutics for the treatment of cancer. The company's pipeline products ...

Triphase Accelerator Corp Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14062018] Prices from USD $250

SummaryTriphase Accelerator Corp Triphase Accelerator is a biotechnology development company that acquires and develops novel therapeutics for the treatment of cancer. The company's pipeline products ...

Scientists Present Ideas for Next-Gen Accelerator Experiments

NewsAn advisory committee is evaluating proposals for first experiments at SLAC's future FACET-II accelerator facility.

6 startups enter Boston Scientific-funded medtech accelerator

Six medtech startups have been accepted into startup accelerator gener8tor's second gBETA Medtech accelerator, a Boston Scien -More- 

Paving the way: An accelerator on a microchip

(Technische Universitat Darmstadt) Darmstadt, Germany, November 26, 2018. Electrical engineers in the accelerator physics group at TU Darmstadt have developed a design for a laser-driven electron acce...

Ky. accelerator partners with universities to create medtech hub

Louisville, Ky.-based health care-focused startup accelerator XLerateHealth is collaborating with the University of Kentucky, -More- 

UK accelerator secures cell and gene therapy production licenses

Autolus, Cell Medica, Adaptimmune and Freeline are some of the companies already working with the accelerator.

XLerateHealth Accelerator Unveils Its Sixth Class of 10 Digital Health Startups

XLerateHealth, a Louisville-based healthcare accelerator, today announced it has selected ten companies to participate in their sixth cohort of companies. The accelerator’s 12-week intensive program...

PubMed Articles [58 Associated PubMed Articles listed on BioPortfolio]

Electrochemical Property-Structure Correlation for Ni-based Layered Na-ion Cathodes.

A class of Ni-based layered NaxNi0.5Mn0.3Co0.2O2 oxide composites is prepared via a solid-state process. Mixed P-, O- and P-/O-type phases can be obtained by tuning the Na content and annealing temper...

Design considerations for a Pulse Line Ion Accelerator (PLIA)-based PET isotope generator.

Positron emission tomography (PET) imaging remains limited by the cost associated with on-site production of short half-life, positron emitting isotopes. In this work, we examine the use of a pulse li...

Dedicated linear accelerator radiosurgery for classical trigeminal neuralgia: a single-center experience with long term follow-up.

During the past decades, stereotactic radiosurgery (SRS) and Gamma Knife in particular have proven its safety and efficacy for drug-resistant classical trigeminal neuralgia (CTN). However, few large s...

First Six Dimensional Phase Space Measurement of an Accelerator Beam.

This Letter presents the first complete six dimensional phase space measurement of a beam in an accelerator. The measurement was made on the Spallation Neutron Source Beam Test Facility. The data reve...

Observation of Laser Power Amplification in a Self-Injecting Laser Wakefield Accelerator.

We report on the depletion and power amplification of the driving laser pulse in a strongly driven laser wakefield accelerator. Simultaneous measurement of the transmitted pulse energy and temporal sh...

Clinical Trials [20 Associated Clinical Trials listed on BioPortfolio]

3DV+TPS Applied to Radiotherapy for Nasopharyngeal Carcinoma

Verify that 3DV+TPS is non-inferior compared to existing imported TPS and superior to existing domestic TPS.

First-In Man (FIM) Study MR-Linac

Investigational device is the Magnetic resonance imager linear accelerator. Five (5) patients with bone metastases will be treated with palliative intention in this study. The goal is to c...

Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder

The aim of this study is to evaluate, through a pilot study with about ten cases, if bilateral ventral capsulotomy by linear accelerator enable modification of obsessive-compulsive symptom...

Stereotactic Body Radio Therapy (SBRT) for Early-Stage Non Small Cell Lung Cancer (NSCLC)

The purpose of this study is to evaluate local disease control after 2 years in patients with non-metastatic, non-operated non-small-cell lung cancer treated by radiotherapy. Eligible pat...

Autoimmune Diabetes Accelerator Prevention Trial

The autoimmune diabetes ACCELERATOR PREVENTION TRIAL (adAPT) is based on the accelerator hypothesis. The trial is designed to establish whether metformin, an oral hypoglycaemic agent that ...

Companies [243 Associated Companies listed on BioPortfolio]

Triphase Accelerator Corporation

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to adva...

Triphase

Triphase is a private, oncology- focused accelerator dedicated to advancing compelling, well differentiated drugs through human proof of concept (Phase II) faster and more efficie...

Accelerator Life Science Partners

Accelerator Life Science Partners catalyzes the development and commercialization of breakthrough biotechnology innovations. Accelerator is a trusted partner that provides the com...

Cydan

Cydan is an orphan drug accelerator that identifies and de-risks assets with therapeutic and commercial potential. The accelerator’s model evaluates programs for treating rar...

SKTA Innopartners

SKTA Innovation Accelerator is a different kind of accelerator based in Silicon Valley. We seed core technology startups by matching entrepreneurs with Strategic Partners committe...

More Information about "Triphase Accelerator Corporation" on BioPortfolio

We have published hundreds of Triphase Accelerator Corporation news stories on BioPortfolio along with dozens of Triphase Accelerator Corporation Clinical Trials and PubMed Articles about Triphase Accelerator Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Triphase Accelerator Corporation Companies in our database. You can also find out about relevant Triphase Accelerator Corporation Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record